Public–private collaborations in drug development: boosting innovation or alleviating risk?

Thomas Crispeels, Jurgen Willems and Ilse Scheerlinck

Public Management Review, 2018, vol. 20, issue 2, 273-292

Abstract: Consistent with popular belief among certain academics, practitioners, and policy makers, we hypothesize that collaboration between private and public organizations promotes success. We test this hypothesis for data on clinical trial success. Contrary to this popular belief, our results do not support the beneficial effect of within- and cross-sector collaborations. In contrast, we find that trials from single private companies are four times more likely to be successful than are trials in which public and private organizations collaborate. Hence, our results indicate that companies engage with public partners to mitigate development risks, not to exchange knowledge or technologies with them.

Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
http://hdl.handle.net/10.1080/14719037.2017.1302247 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:rpxmxx:v:20:y:2018:i:2:p:273-292

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/rpxm20

DOI: 10.1080/14719037.2017.1302247

Access Statistics for this article

Public Management Review is currently edited by Stephen P. Osborne

More articles in Public Management Review from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().